Evaluation of the efficacy of natural product with placebo on renal stone therapy

Evaluating the effect of selected natural product (Bore armani and Raphanus niger Mill. combination/mixture) compared to placebo in the treatment of kidney stones, a double-blind study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200112046087N2

Enrollment

Registered

2020-05-18

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone. Calculus of kidney

Interventions

Intervention 1: Patients with kidney stones 10 mm in size and smaller than those diagnosed by ultrasound are screened by a physician based on their blood and urine tests. Patients take 2 oral capsules

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Kidney or ureteral stones less than 10 mm in size, according to ultrasound reports Pregnancy and lactation in women No kidney tumors Lack of emergency conditions in the patient No insulin-dependent diabetes Not taking any herbal medicine for kidney stones Blood creatinine less than 1.4 mg/dl 20-60 years

Exclusion criteria

Exclusion criteria: Severe urinary tract infection Emergency cases of kidney stones or the need for surgical intervention

Design outcomes

Primary

Measure	Time frame
The size of the stone. Timepoint: Before entering the study (before starting the drug) and 8 days after starting the drug. Method of measurement: Kidney ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza ilkhani

Shahid Beheshti University of Medical Sciences

ilkhanir@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026